Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

$2.25M Penalty for Missouri Pharmaceuticals Plant

By Pharmaceutical Processing | March 15, 2013

 ST. LOUIS (AP) — Teva Pharmaceuticals USA Inc. will pay a $2.25 million penalty for violations that included allowing fluorescent green discharge into a river at its plant in northeast Missouri, state and federal officials said Thursday.

Teva makes antibiotics at a plant outside of Mexico, Mo., about 120 miles northwest of St. Louis. Missouri Attorney General Chris Koster said the green discharge flowed into the Salt River from a wastewater treatment plant in 2008. Koster’s office said it discolored the river for 22 miles, all the way to Mark Twain Lake. The discharge was traced to the Teva facility.

“Missourians have a right to expect local businesses to comply with environmental laws designed to protect the state’s valuable water resources,” Koster said.

Nanci Gonder, a spokeswoman for Koster, said there were no known human or wildlife illnesses resulting from the discharge.

The EPA cited air pollution, water pollution and wastewater violations, some of which were uncovered by inspections dating to 2007, even before the discharge was found in Salt River.

“With numerous violations over a period of years, Teva’s actions resulted in significant environmental damage to the air and water,” said EPA Region 7 Administrator Karl Brooks. “The penalty and injunctive relief required by this agreement send a strong message to Teva and others that businesses must comply with environmental laws.”

Teva said in a statement that the issues leading to the penalty “have been addressed and the facility is operating in compliance with all relevant environmental laws. Additionally, the site continues to take proactive steps to reduce its environmental footprint.”

The EPA said that in addition to the penalty, Teva must pay more than $2.5 million for anti-pollution upgrades at the plant. The company also will pay the state $150,000 for things such as investigation costs and damage to natural resources, Koster’s office said.

Teva Pharmaceuticals USA is a division of Teva Industries Ltd., based in Israel. Its website says it employs 46,000 people in 60 countries, including 9,000 in the U.S.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE